Announcements Trials
Browse Landscape

Phase

Phase 2 28Phase 3 5Phase 1 5Phase 4 2Phase NA 1Phase 2/3 1

Status

Unknown 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 10Mesothelioma 3Lung Neoplasms 2Adenocarcinoma of Lung 2Adenocarcinoma 2Thoracic Neoplasms 1Non-Small Cell Lung Cancer Metastatic 1Lung Diseases 1Locally Advanced Malignant Neoplasm 1Advanced Non-squamous Non-small-cell Lung Cancer 1

Interventions

Pemetrexed 2endostar protein 1Erlotinib Hydrochloride 1Endostatins 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Adenocarcinoma of Lung × Pemetrexed × Clear all
NCT02804646 2016-06-21

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Anhui Provincial Hospital

Phase 4 Unknown
100 enrolled
Thoracic

Adenocarcinoma of Lung

NCT02399566 2015-03-26

Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma

Hunan Province Tumor Hospital

Phase 4 Unknown
300 enrolled
Thoracic

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡